Form 8-K - Current report:
SEC Accession No. 0001628280-17-003253
Filing Date
2017-03-31
Accepted
2017-03-31 17:22:29
Documents
3
Period of Report
2017-03-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K - CALDOLOR PRESS RELEASE a8k-caldolorpressrelease.htm 8-K 29470
2 EXHIBIT 99.1 - PRESS RELEASE CALDOLOR pressrelease-caldolor.htm EX-99.1 13370
3 cumberlanda03.gif GRAPHIC 10657
  Complete submission text file 0001628280-17-003253.txt   58644
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 17731435
SIC: 2834 Pharmaceutical Preparations